Mayne Pharma Group (OTCMKTS:MAYNF) Shares Climb 1.1% – Time to Buy?
by Jessica Moore · The Cerbat GemMayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares rose 1.1% on Thursday. The stock traded as high as $1.87 and last traded at $1.87. 350 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 3,560 shares. The stock had previously closed at $1.85.
Mayne Pharma Group Stock Up 1.1%
The business’s fifty day moving average is $2.05 and its two-hundred day moving average is $1.89.
About Mayne Pharma Group
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company that develops, manufactures, and commercializes branded and generic prescription medicines. Its activities include product development, regulatory support, manufacturing, and the distribution of pharmaceutical products through its own commercial operations and external partners.
The company has focused on therapeutic areas including dermatology, women’s health, and other specialty-care markets. Its portfolio has included prescription products such as oral and topical medicines, as well as contraceptive and other branded therapies.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market